Skip to main content
. 2014 Sep 15;8:1745–1755. doi: 10.2147/OPTH.S67730

Figure 6.

Figure 6

Percentages of patients receiving intraocular pressure-lowering drugs in both patient groups at different times of 6, 12, 18, and 24 months postoperatively.

Notes: Shaded columns represent group A (mitomycin C + bevacizumab) and group B (mitomycin C).